Skip to content
2000
Volume 7, Issue 8
  • ISSN: 1389-5575
  • E-ISSN: 1875-5607

Abstract

FTY720, the pharmacological analog of S1P, acts as an agonist of sphingosine-1-phosphate receptors, resulting in the inhibition of lymphocyte egress from secondary lymphoid tissues and thymocytes from the thymus, peripheral lymphopenia and interfering with normal functions of several other cell types. FTY720 has been clinically tried for transplantation and multiple sclerosis, showing promising protective effects. This review will summarize potential applications and effects of FTY720.

Loading

Article metrics loading...

/content/journals/mrmc/10.2174/138955707781387948
2007-08-01
2025-06-17
Loading full text...

Full text loading...

/content/journals/mrmc/10.2174/138955707781387948
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test